Phase 1 Start~month

Phase 1 Start: A Phase 1 Study With Expansion of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (M

Other upcoming events for MRKR

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

    Phase 1 Start: A Phase 1 Study With Expansion of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (M — MRKR Phase 1 Start | BioSniper